Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood cancer and heart risk: can inflammation proteins predict trouble?

NCT ID NCT06692894

First seen Feb 03, 2026 · Last updated Apr 29, 2026 · Updated 12 times

Summary

This study looks at why people with myelodysplastic syndromes (MDS), a type of blood cancer, are more likely to develop heart disease or stroke. Researchers will measure inflammation-related proteins in the blood of 30 adults with MDS over six months. The goal is to find out if these proteins can help predict heart problems, leading to better monitoring and care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES, ADULT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Vermont

    RECRUITING

    Burlington, Vermont, 05495-2038, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.